Jan Vanco
Docent
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
A series of eight N ‐heterocyclic carbenes (NHC) gold(I) complexes, involving 1,3‐bis(2,6‐diisopropylphenyl)imidazol‐2‐ylidene (iPr) ligand in combination with 6‐mercaptopurine derivatives (HL 1–8 ), has been prepared and thoroughly characterized, including elemental analysis, mass spectrometry, infrared and multinuclear NMR spectroscopy, and single crystal X‐ray analysis. The complexes, showing general composition of [Au (iPr)(L n )] 1 – 8 , were evaluated for their in vitro cytotoxicity against four human cancer cell lines including A2780 (ovarian) and A2780R (ovarian Cisplatin resistant), PC3 (prostate) and MCF‐7 (breast), and normal human MRC‐5 cells (lung fibroblasts). The complexes revealed significant cytotoxicity, with the best IC 50 values ≈ 3.4–6.4 μM against A2780 and reasonable selectivity. Cellular effects of the selected complexes on the A2780 cells were evaluated using various flow cytometry assays. Complexes 1 , 3 , and 4 showed a strong pro‐apoptotic effect and a strong effect on the loss of mitochondrial membrane potential. These findings indicate that their major mechanism of action is based on the collapse of the mitochondrial metabolism and activation of the intrinsic signaling pathway of apoptosis, consequently resulting in cell death. The complexes 1 – 8 revealed only negligible effect on the production of inflammatory‐related cytokine (TNF‐α), as well as the activation of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) or peroxisome proliferator‐activated receptor gamma (PPARγ). Moreover, the shotgun proteomic analysis was performed, and the obtained results suggest that the mechanism of action of complexes 1 , 3 , and 4 differs somewhat from that of Auranofin .
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (11)
Lorenzo Biancalana
University of Pisa
FABIO MARCHETTI
Full Professor (Professore Ordinario)
University of Pisa
Stefano Zacchini
Professor
University of Bologna
Tarita Biver
Associate Professor
University of Pisa
Jaromir Marek
associate professor
Masaryk University
Johannes A Schmid
Full Professor
Medical University of Vienna
Zdeněk Trávníček
Head of the Division
Palacký University, Olomouc
Jan Hošek
associate professor
Masaryk University
Giorgio Zoppellaro
Senior scientist
VSB - Technical University of Ostrava
Zdeněk Dvořák
Palacký University, Olomouc
Rene Lenobel
senior researcher
Palacký University, Olomouc
Make your next move.
Prepare your application
Review drafts before you send them.